Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. [electronic resource]
Producer: 20091204Description: 5217-25 p. digitalISSN:- 1552-5783
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Anterior Chamber
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Aqueous Humor -- metabolism
- Bevacizumab
- Cell Proliferation -- drug effects
- Cells, Cultured
- Cicatrix -- etiology
- Conjunctival Diseases -- etiology
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Female
- Fibroblasts -- metabolism
- Glaucoma, Open-Angle -- surgery
- Humans
- Injections
- Intraocular Pressure
- Postoperative Complications
- Rabbits
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Tonometry, Ocular
- Trabeculectomy
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.